Shares of Altimmune (NASDAQ:ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors on ...

Chicago Sun-Times Editorial Page Editor Lorraine Forte is taking a buyout offer as the deadline for Chicago Public Media ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Private equity managers have a bad case of indigestion. Blackstone , KKR , CVC Capital Partners and their peers are ...

The company said it was exploring options, including a potential sale or debt refinancing, just a day after it launched eight ...

The employee, who tagged Indian bosses as “toxic”, stated that they are set to join one of the FAANG companies. However, ...

NEW YORK] Alimentation Couche-Tard will seek to address antitrust concerns of Japan’s Seven & i as the Canadian company’s ...

The Australian Competition and Consumer Commission (ACCC) has cited competition concerns in its preliminary assessment of DP ...

Nissan chief steps down after Japanese car giant reports dismal results The chief executive of Japanese car giant Nissan, ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

The 26-year-old firm’s latest fund is about two-thirds bigger than its last capital raise of $1.25 billion in 2022, and beat ...

The business will spend more than £600 million on the move, which it called the “big Nationwide thank you”. Nationwide said ...